Rosiglitazone protects against palmitate-induced pancreatic beta-cell death by activation of autophagy via 5′-AMP-activated protein kinase modulation
J Wu, J Wu, L Yang, L Wei, D Zou - Endocrine, 2013 - Springer
Promoting beta-cell survival is crucial for the prevention of beta-cell failure in diabetes.
Thiazolidinediones, a widely used drug to improve insulin sensitivity in clinical practice, is …
Thiazolidinediones, a widely used drug to improve insulin sensitivity in clinical practice, is …
Rosiglitazone protects against palmitate-induced pancreatic beta-cell death by activation of autophagy via 5'-AMP-activated protein kinase modulation
J Wu, JJ Wu, LJ Yang, LX Wei, DJ Zou - Endocrine, 2013 - hero.epa.gov
Promoting beta-cell survival is crucial for the prevention of beta-cell failure in diabetes.
Thiazolidinediones, a widely used drug to improve insulin sensitivity in clinical practice, is …
Thiazolidinediones, a widely used drug to improve insulin sensitivity in clinical practice, is …
[引用][C] Rosiglitazone protects against palmitate-induced pancreatic beta-cell death by activation of autophagy via 5′-AMP-activated protein kinase modulation
J Wu, J Wu, L Yang, L Wei, D Zou - Endocrine, 2012 - cir.nii.ac.jp
Rosiglitazone protects against palmitate-induced pancreatic beta-cell death by activation of
autophagy via 5′-AMP-activated protein kinase modulation | CiNii Research CiNii 国立情報学 …
autophagy via 5′-AMP-activated protein kinase modulation | CiNii Research CiNii 国立情報学 …
Rosiglitazone protects against palmitate-induced pancreatic beta-cell death by activation of autophagy via 5′-AMP-activated protein kinase modulation.
J Wu, J Wu, L Yang, L Wei, D Zou - Endocrine (1355008X), 2013 - search.ebscohost.com
Promoting beta-cell survival is crucial for the prevention of beta-cell failure in diabetes.
Thiazolidinediones, a widely used drug to improve insulin sensitivity in clinical practice, is …
Thiazolidinediones, a widely used drug to improve insulin sensitivity in clinical practice, is …
Rosiglitazone protects against palmitate-induced pancreatic beta-cell death by activation of autophagy via 5′-AMP-activated protein kinase modulation
J Wu, J Wu, L Yang, L Wei, D Zou - Endocrine, 2013 - infona.pl
Promoting beta-cell survival is crucial for the prevention of beta-cell failure in diabetes.
Thiazolidinediones, a widely used drug to improve insulin sensitivity in clinical practice, is …
Thiazolidinediones, a widely used drug to improve insulin sensitivity in clinical practice, is …
Rosiglitazone protects against palmitate-induced pancreatic beta-cell death by activation of autophagy via 5'-AMP-activated protein kinase modulation.
J Wu, JJ Wu, LJ Yang, LX Wei, DJ Zou - Endocrine, 2012 - europepmc.org
Promoting beta-cell survival is crucial for the prevention of beta-cell failure in diabetes.
Thiazolidinediones, a widely used drug to improve insulin sensitivity in clinical practice, is …
Thiazolidinediones, a widely used drug to improve insulin sensitivity in clinical practice, is …
Rosiglitazone protects against palmitate-induced pancreatic beta-cell death by activation of autophagy via 5'-AMP-activated protein kinase modulation
J Wu, J Wu, L Yang, L Wei, D Zou - Endocrine, 2013 - pubmed.ncbi.nlm.nih.gov
Promoting beta-cell survival is crucial for the prevention of beta-cell failure in diabetes.
Thiazolidinediones, a widely used drug to improve insulin sensitivity in clinical practice, is …
Thiazolidinediones, a widely used drug to improve insulin sensitivity in clinical practice, is …
Rosiglitazone protects against palmitate-induced pancreatic beta-cell death by activation of autophagy via 5′-AMP-activated protein kinase modulation.
J Wu, J Wu, L Yang, L Wei, D Zou - Endocrine (1355008X), 2013 - search.ebscohost.com
Promoting beta-cell survival is crucial for the prevention of beta-cell failure in diabetes.
Thiazolidinediones, a widely used drug to improve insulin sensitivity in clinical practice, is …
Thiazolidinediones, a widely used drug to improve insulin sensitivity in clinical practice, is …